ACSL1 and periodontitis: Likewise, methotrexate-loaded EVs derived from human umbilical cord mesenchymal stem cells suppressed proinflammatory macrophage activation through acyl-CoA synthetase-1 (ACSL1) downregulation and OXPHOS restoration, ultimately improving therapeutic outcomes in periodontitis [134,135].